{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:12:11Z","timestamp":1791403931548,"version":"4.3.3"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,21]],"date-time":"2012-10-21T00:00:00Z","timestamp":1350777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00213-012-2904-9","type":"journal-article","created":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T10:10:39Z","timestamp":1350727839000},"page":"295-305","source":"Crossref","is-referenced-by-count":22,"title":["Effects of mood stabilizers on marble-burying behavior in mice"],"prefix":"10.1007","volume":"226","author":[{"given":"Nobuaki","family":"Egashira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunori","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomiko","family":"Niki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryozo","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,21]]},"reference":[{"key":"2904_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neubiorev.2011.04.006","volume":"36","author":"N Albelda","year":"2012","unstructured":"Albelda N, Joel D (2012) Animal models of obsessive\u2013compulsive disorder: exploring pharmacology and neural substrates. Neurosci Biobehav Rev 36:47\u201363","journal-title":"Neurosci Biobehav Rev"},{"key":"2904_CR2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0028-3908(99)00058-1","volume":"38","author":"AF Ambr\u00f3sio","year":"1999","unstructured":"Ambr\u00f3sio AF, Silva AP, Malva JO, Soares-da-Silva P, Carvalho AP, Carvalho CM (1999) Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists. Neuropharmacology 38:1349\u20131359","journal-title":"Neuropharmacology"},{"key":"2904_CR3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00213-004-1847-1","volume":"174","author":"PD Arnold","year":"2004","unstructured":"Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA (2004) Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive\u2013compulsive disorder: a preliminary study. Psychopharmacology (Berl) 174:530\u2013538","journal-title":"Psychopharmacology (Berl)"},{"key":"2904_CR4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archpsyc.63.7.769","volume":"63","author":"PD Arnold","year":"2006","unstructured":"Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL (2006) Glutamate transporter gene SLC1A1 associated with obsessive\u2013compulsive disorder. Arch Gen Psychiatry 63:769\u2013776","journal-title":"Arch Gen Psychiatry"},{"key":"2904_CR5","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1471-4159.1992.tb11001.x","volume":"59","author":"CS Biggs","year":"1992","unstructured":"Biggs CS, Pearce BR, Fowler LJ, Whitton PS (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study. J Neurochem 59:1702\u20131708","journal-title":"J Neurochem"},{"key":"2904_CR6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.mp.4001823","volume":"11","author":"MH Bloch","year":"2006","unstructured":"Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF (2006) A systematic review: antipsychotic augmentation with treatment refractory obsessive\u2013compulsive disorder. Mol Psychiatr 11:622\u2013632","journal-title":"Mol Psychiatr"},{"key":"2904_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archpsyc.1990.01810140081011","volume":"47","author":"DL Braff","year":"1990","unstructured":"Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47:181\u2013188","journal-title":"Arch Gen Psychiatry"},{"key":"2904_CR8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00213-003-1421-2","volume":"169","author":"SA Brody","year":"2003","unstructured":"Brody SA, Geyer MA, Large CH (2003) Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice. Psychopharmacology (Berl) 169:240\u2013246","journal-title":"Psychopharmacology (Berl)"},{"key":"2904_CR9","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1300733","volume":"30","author":"K Chakrabarty","year":"2005","unstructured":"Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S (2005) Glutamatergic dysfunction in OCD. Neuropsychopharmacology 30:1735\u20131740","journal-title":"Neuropsychopharmacology"},{"key":"2904_CR10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pharmthera.2010.07.006","volume":"128","author":"CT Chiu","year":"2010","unstructured":"Chiu CT, Chuang DM (2010) Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther 128:281\u2013304","journal-title":"Pharmacol Ther"},{"key":"2904_CR11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2005.04.043","volume":"58","author":"V Coric","year":"2005","unstructured":"Coric V, Taskiran S, Pittenger C, Wasylink S, Mathalon DH, Valentine G, Saksa J, Wu YT, Gueorguieva R, Sanacora G, Malison RT, Krystal JH (2005) Riluzole augmentation in treatment-resistant obsessive\u2013compulsive disorder: an open-label trial. Biol Psychiatry 58:424\u2013428","journal-title":"Biol Psychiatry"},{"key":"2904_CR12","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0028-3908(00)00051-4","volume":"39","author":"MO Cunningham","year":"2000","unstructured":"Cunningham MO, Jones RS (2000) The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro. Neuropharmacology 39:2139\u20132146","journal-title":"Neuropharmacology"},{"key":"2904_CR13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s002130050148","volume":"128","author":"A Dalvi","year":"1996","unstructured":"Dalvi A, Rodgers RJ (1996) GABAergic influences on plus-maze behaviour in mice. Psychopharmacology (Berl) 128:380\u2013397","journal-title":"Psychopharmacology (Berl)"},{"key":"2904_CR14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/S1461145710000106","volume":"14","author":"L Danovich","year":"2011","unstructured":"Danovich L, Weinreb O, Youdim MB, Silver H (2011) The involvement of GABAA receptor in the molecular mechanisms of combined selective serotonin reuptake inhibitor-antipsychotic treatment. Int J Neuropsychopharmacol 14:143\u2013155","journal-title":"Int J Neuropsychopharmacol"},{"key":"2904_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2007.02.019","volume":"563","author":"N Egashira","year":"2007","unstructured":"Egashira N, Harada S, Okuno R, Matsushita M, Nishimura R, Mishima K, Iwasaki K, Orito K, Fujiwara M (2007) Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine. Eur J Pharmacol 563:149\u2013154","journal-title":"Eur J Pharmacol"},{"key":"2904_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1254\/jphs.08160SC","volume":"108","author":"N Egashira","year":"2008","unstructured":"Egashira N, Okuno R, Abe M, Matsushita M, Mishima K, Iwasaki K, Oishi R, Nishimura R, Matsumoto Y, Fujiwara M (2008a) Calcium-channel antagonists inhibit marble-burying behavior in mice. J Pharmacol Sci 108:140\u2013143","journal-title":"J Pharmacol Sci"},{"key":"2904_CR17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2008.01.035","volume":"586","author":"N Egashira","year":"2008","unstructured":"Egashira N, Okuno R, Harada S, Matsushita M, Mishima K, Iwasaki K, Nishimura R, Oishi R, Fujiwara M (2008b) Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive\u2013compulsive disorder. Eur J Pharmacol 586:164\u2013170","journal-title":"Eur J Pharmacol"},{"key":"2904_CR18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00213-009-1547-y","volume":"205","author":"DG Flood","year":"2009","unstructured":"Flood DG, Choinski M, Marino MJ, Gasior M (2009) Mood stabilizers increase prepulse inhibition in DBA\/2NCrl mice. Psychopharmacology (Berl) 205:369\u2013377","journal-title":"Psychopharmacology (Berl)"},{"key":"2904_CR19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejphar.2008.11.013","volume":"602","author":"MM Foreman","year":"2009","unstructured":"Foreman MM, Hanania T, Eller M (2009) Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test. Eur J Pharmacol 602:316\u2013320","journal-title":"Eur J Pharmacol"},{"key":"2904_CR20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archpsyc.1989.01810010038006","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS (1989) Efficacy of fluvoxamine in obsessive\u2013compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry 46:36\u201344","journal-title":"Arch Gen Psychiatry"},{"key":"2904_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1092852900006908","volume":"8","author":"JH Greist","year":"2003","unstructured":"Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, Okasha A, Swinson RP, Zohar J, World Council of Anxiety (2003) WCA recommendations for the long-term treatment of obsessive\u2013compulsive disorder in adults. CNS Spectr 8:7\u201316","journal-title":"CNS Spectr"},{"key":"2904_CR22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.bjp.0706108","volume":"144","author":"K Hirano","year":"2005","unstructured":"Hirano K, Kimura R, Sugimoto Y, Yamada J, Uchida S, Kato Y, Hashimoto H, Yamada S (2005) Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. Brit J Pharmacol 144:695\u2013702","journal-title":"Brit J Pharmacol"},{"key":"2904_CR23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.biopsych.2005.01.040","volume":"57","author":"K Hoenig","year":"2005","unstructured":"Hoenig K, Hochrein A, Quednow BB, Maier W, Wagner M (2005) Impaired prepulse inhibition of acoustic startle in obsessive\u2013compulsive disorder. Biol Psychiatry 57:1153\u20131158","journal-title":"Biol Psychiatry"},{"key":"2904_CR24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.yic.0000199453.54799.cc","volume":"21","author":"E Hollander","year":"2006","unstructured":"Hollander E, Dell\u2019Osso B (2006) Topiramate plus paroxetine in treatment-resistant obsessive\u2013compulsive disorder. Int Clin Psychopharmacol 21:189\u2013191","journal-title":"Int Clin Psychopharmacol"},{"key":"2904_CR25","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00517-8","volume":"380","author":"J Ichikawa","year":"1999","unstructured":"Ichikawa J, Meltzer HY (1999) Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation. Eur J Pharmacol 380:R1\u2013R3","journal-title":"Eur J Pharmacol"},{"key":"2904_CR26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainres.2005.05.005","volume":"1049","author":"J Ichikawa","year":"2005","unstructured":"Ichikawa J, Dai J, Meltzer HY (2005) Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT1A receptor agonism. Brain Res 1049:182\u2013190","journal-title":"Brain Res"},{"key":"2904_CR27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1254\/jjp.68.65","volume":"68","author":"Y Ichimaru","year":"1995","unstructured":"Ichimaru Y, Egawa T, Sawa A (1995) 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol 68:65\u201370","journal-title":"Jpn J Pharmacol"},{"key":"2904_CR28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00213-006-0631-9","volume":"190","author":"LH Jacobson","year":"2007","unstructured":"Jacobson LH, Bettler B, Kaupmann K, Cryan JF (2007) Behavioral evaluation of mice deficient in GABAB1 receptor isoforms in tests of unconditioned anxiety. Psychopharmacology (Berl) 190:541\u2013553","journal-title":"Psychopharmacology (Berl)"},{"key":"2904_CR29","volume-title":"Obsessive\u2013compulsive disorders: practical management","author":"MA Jenike","year":"1998","unstructured":"Jenike MA, Baier L, Minichiello WE (1998) Obsessive\u2013compulsive disorders: practical management. Mosby, St. Louis"},{"key":"2904_CR30","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1111\/j.1460-9568.2005.04042.x","volume":"21","author":"D Joel","year":"2005","unstructured":"Joel D, Doljansky J, Schiller D (2005) \u2018Compulsive\u2019 lever pressing in rats is enhanced following lesions to the orbital cortex, but not to the basolateral nucleus of the amygdala or to the dorsal medial prefrontal cortex. Eur J Neurosci 21:2252\u20132262","journal-title":"Eur J Neurosci"},{"key":"2904_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","volume":"37","author":"CU Johannessen","year":"2000","unstructured":"Johannessen CU (2000) Mechanisms of action of valproate: a commentatory. Neurochem Int 37:103\u2013110","journal-title":"Neurochem Int"},{"key":"2904_CR32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2007.03.003","volume":"565","author":"MP Kaster","year":"2007","unstructured":"Kaster MP, Raupp I, Binfar\u00e9 RW, Andreatini R, Rodrigues AL (2007) Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system. Eur J Pharmacol 565:119\u2013124","journal-title":"Eur J Pharmacol"},{"key":"2904_CR33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0928-0987(97)10009-4","volume":"5","author":"P Krogsgaardlarsen","year":"1997","unstructured":"Krogsgaardlarsen P, Frolund B, Kristiansen U, Frydenvang K, Ebert B (1997) GABAA and GABAB receptor agonists, partial agonists, antagonists and modulators: design and therapeutic prospects. Eur J Pharm Sci 5:355\u2013384","journal-title":"Eur J Pharm Sci"},{"key":"2904_CR34","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0026-895X(24)13073-8","volume":"54","author":"CC Kuo","year":"1998","unstructured":"Kuo CC (1998) A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels. Mol Pharmacol 54:712\u2013721","journal-title":"Mol Pharmacol"},{"key":"2904_CR35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-4328(97)00162-9","volume":"94","author":"T Londei","year":"1998","unstructured":"Londei T, Valentini AMV, Leone VG (1998) Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour. Behav Brain Res 94:249\u2013254","journal-title":"Behav Brain Res"},{"key":"2904_CR36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","volume":"58","author":"W L\u00f6scher","year":"1999","unstructured":"L\u00f6scher W (1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 58:31\u201359","journal-title":"Prog Neurobiol"},{"key":"2904_CR37","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1254\/jphs.FP0050144","volume":"99","author":"M Matsushita","year":"2005","unstructured":"Matsushita M, Egashira N, Harada S, Okuno R, Mishima K, Iwasaki K, Nishimura R, Fujiwara M (2005) Perospirone, a novel antipsychotic drugs, inhibits marble-burying behavior via 5-HT1A receptor in mice: implications for obsessive\u2013compulsive disorder. J Pharmacol Sci 99:154\u2013159","journal-title":"J Pharmacol Sci"},{"key":"2904_CR38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neubiorev.2007.09.005","volume":"32","author":"L Menzies","year":"2008","unstructured":"Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET (2008) Integrating evidence from neuroimaging and neuropsychological studies of obsessive\u2013compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev 32:525\u2013549","journal-title":"Neurosci Biobehav Rev"},{"key":"2904_CR39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neuropharm.2007.07.002","volume":"53","author":"G Munro","year":"2007","unstructured":"Munro G, Erichsen HK, Mirza NR (2007) Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety. Neuropharmacology 53:609\u2013618","journal-title":"Neuropharmacology"},{"key":"2904_CR40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/sj.bjp.0704285","volume":"134","author":"T Murakami","year":"2001","unstructured":"Murakami T, Okada M, Kawata Y, Zhu G, Kamata A, Kaneko S (2001) Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis. Br J Pharmacol 134:507\u2013520","journal-title":"Br J Pharmacol"},{"key":"2904_CR41","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1523\/JNEUROSCI.15-07-05065.1995","volume":"15","author":"K Obrietan","year":"1995","unstructured":"Obrietan K, van den Pol AN (1995) GABA neurotransmission in the hypothalamus: developmental reversal from Ca2+ elevating to depressing. J Neurosci 15:5065\u20135077","journal-title":"J Neurosci"},{"key":"2904_CR42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1152\/jn.1999.82.1.94","volume":"82","author":"K Obrietan","year":"1999","unstructured":"Obrietan K, van den Pol AN (1999) GABAB receptor-mediated regulation of glutamate-activated calcium transients in hypothalamic and cortical neuron development. J Neurophysiol 82:94\u2013102","journal-title":"J Neurophysiol"},{"key":"2904_CR43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0920-1211(97)00042-9","volume":"28","author":"M Okada","year":"1997","unstructured":"Okada M, Hirano T, Mizuno K, Chiba T, Kawata Y, Kiryu K, Wada K, Tasaki H, Kaneko S (1997) Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus. Epilepsy Res 28:143\u2013153","journal-title":"Epilepsy Res"},{"key":"2904_CR44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0920-1211(98)00025-4","volume":"31","author":"M Okada","year":"1998","unstructured":"Okada M, Hirano T, Mizuno K, Kawata Y, Wada K, Murakami T, Tasaki H, Kaneko S (1998) Effects of carbamazepine on hippocampal serotonergic system. Epilepsy Res 31:187\u2013198","journal-title":"Epilepsy Res"},{"key":"2904_CR45","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1124\/jpet.105.090845","volume":"315","author":"JC Ong","year":"2005","unstructured":"Ong JC, Brody SA, Large CH, Geyer MA (2005) An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition. J Pharmacol Exp Ther 315:1163\u20131171","journal-title":"J Pharmacol Exp Ther"},{"key":"2904_CR46","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1523\/JNEUROSCI.16-20-06414.1996","volume":"16","author":"DF Owens","year":"1996","unstructured":"Owens DF, Boyce LH, Davis MB, Kriegstein AR (1996) Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imaging. J Neurosci 16:6414\u20136423","journal-title":"J Neurosci"},{"key":"2904_CR47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.pnpbp.2006.04.013","volume":"30","author":"M Pasquini","year":"2006","unstructured":"Pasquini M, Biondi M (2006) Mematine augmentation for refractory obsessive\u2013compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatr 30:1173\u20131175","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"key":"2904_CR48","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1176\/appi.ajp.162.11.2191-a","volume":"162","author":"M Poyurovsky","year":"2005","unstructured":"Poyurovsky M, Weizman R, Weizman A, Koran L (2005) Memantine for treatment-resistant OCD. Am J Psychiatry 162:2191\u20132192","journal-title":"Am J Psychiatry"},{"key":"2904_CR49","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0193-953X(18)30205-3","volume":"15","author":"SA Rasmussen","year":"1992","unstructured":"Rasmussen SA, Eisen JL (1992) The epidemiology and clinical features of obsessive\u2013compulsive disorder. Psychiatr Clin North Am 15:743\u2013758","journal-title":"Psychiatr Clin North Am"},{"key":"2904_CR50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","volume":"5","author":"MA Rogawski","year":"2004","unstructured":"Rogawski MA, L\u00f6scher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5:553\u2013564","journal-title":"Nat Rev Neurosci"},{"key":"2904_CR51","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","volume":"39","author":"DR Rosenberg","year":"2000","unstructured":"Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ (2000) Decrease in caudate glutamatergic concentrations in pediatric obsessive\u2013compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatr 39:1096\u20131103","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"key":"2904_CR52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S1461145701002401","volume":"4","author":"DR Rosenberg","year":"2001","unstructured":"Rosenberg DR, MacMillan SN, Moore GJ (2001) Brain anatomy and chemistry may predict treatment response in paediatric obsessive\u2013compulsive disorder. Int J Neuropsychopharmacol 4:179\u2013190","journal-title":"Int J Neuropsychopharmacol"},{"key":"2904_CR53","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/npp.2009.175","volume":"35","author":"JY Rotge","year":"2010","unstructured":"Rotge JY, Langbour N, Guehl D, Bioulac B, Jaafari N, Allard M, Aouizerate B, Burbaud P (2010) Gray matter alterations in obsessive\u2013compulsive disorder: an anatomic likelihood estimation meta-analysis. Neuropsychopharmacology 35:686\u2013691","journal-title":"Neuropsychopharmacology"},{"key":"2904_CR54","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-2999(92)90294-E","volume":"219","author":"M Santiago","year":"1992","unstructured":"Santiago M, Westerink BHC (1992) The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats. Eur J Pharmacol 219:175\u2013181","journal-title":"Eur J Pharmacol"},{"key":"2904_CR55","first-page":"7","volume":"58","author":"Y Sasson","year":"1997","unstructured":"Sasson Y, Zohar J, Chopra M, Lustig M, Iancu I, Hendler T (1997) Epidemiology of obsessive\u2013compulsive disorder: a world view. J Clin Psychiatr 58:7\u201310","journal-title":"J Clin Psychiatr"},{"key":"2904_CR56","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/npp.2009.208","volume":"35","author":"EA Schilman","year":"2010","unstructured":"Schilman EA, Klavir O, Winter C, Sohr R, Joel D (2010) The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system. Neuropsychopharmacology 35:1026\u20131039","journal-title":"Neuropsychopharmacology"},{"key":"2904_CR57","first-page":"316","volume-title":"Essential psychopharmacology","author":"M Stahl","year":"2000","unstructured":"Stahl M (2000) Neuroscientific basis and practical application. In: Stahl M (ed) Essential psychopharmacology, 2nd edn. Cambridge University Press, New York, pp 316\u2013317","edition":"2"},{"key":"2904_CR58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(96)00265-8","volume":"307","author":"A Stefani","year":"1996","unstructured":"Stefani A, Spadoni F, Siniscalchi A, Bernardi G (1996) Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications. Eur J Pharmacol 307:113\u2013116","journal-title":"Eur J Pharmacol"},{"key":"2904_CR59","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0006-3223(99)00271-1","volume":"47","author":"DJ Stein","year":"2000","unstructured":"Stein DJ (2000) Neurobiology of the obsessive\u2013compulsive spectrum disorders. Biol Psychiatry 47:296\u2013304","journal-title":"Biol Psychiatry"},{"key":"2904_CR60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2011.10.002","volume":"672","author":"Y Sugimoto","year":"2011","unstructured":"Sugimoto Y, Yamamoto M, Tagawa N, Kobayashi Y, Mitsui-Saitoh K, Hotta Y, Yamada J (2011) Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems. Eur J Pharmacol 672:121\u2013125","journal-title":"Eur J Pharmacol"},{"key":"2904_CR61","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.neuropharm.2012.02.012","volume":"62","author":"A Sugiyama","year":"2012","unstructured":"Sugiyama A, Saitoh A, Iwai T, Takahashi K, Yamada M, Sasaki-Hamada S, Oka J, Inagaki M, Yamada M (2012) Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines. Neuropharmacology 62:2489\u20132498","journal-title":"Neuropharmacology"},{"key":"2904_CR62","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0006-3223(93)90300-3","volume":"33","author":"NR Swerdlow","year":"1993","unstructured":"Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL (1993) A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 33:298\u2013301","journal-title":"Biol Psychiatry"},{"key":"2904_CR63","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/jnnp.58.2.192","volume":"58","author":"NR Swerdlow","year":"1995","unstructured":"Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR (1995) Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 58:192\u2013200","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2904_CR64","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00005053-199810000-00002","volume":"186","author":"WC Tam","year":"1998","unstructured":"Tam WC, Sewell KW, Deng HC (1998) Information processing in schizophrenia and bipolar disorder: a discriminant analysis. J Nerv Ment Dis 186:597\u2013603","journal-title":"J Nerv Ment Dis"},{"key":"2904_CR65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","volume":"204","author":"A Thomas","year":"2009","unstructured":"Thomas A, Burant A, Bui N, Graham D, Yuva-Paylor LA, Paylor R (2009) Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl) 204:361\u2013373","journal-title":"Psychopharmacology (Berl)"},{"key":"2904_CR66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2006.09.050","volume":"553","author":"K Umeda","year":"2006","unstructured":"Umeda K, Suemaru K, Todo N, Egashira N, Mishima K, Iwasaki K, Fujiwara M, Araki H (2006) Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice. Eur J Pharmacol 553:157\u2013162","journal-title":"Eur J Pharmacol"},{"key":"2904_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/da.20118","volume":"23","author":"M Ameringen Van","year":"2006","unstructured":"Van Ameringen M, Mancini C, Patterson B, Bennett M (2006) Topiramate augmentation in treatment-resistant obsessive\u2013compulsive disorder: a retrospective, open-label case series. Depress Anxiety 23:1\u20135","journal-title":"Depress Anxiety"},{"key":"2904_CR68","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1097\/00001756-199611250-00048","volume":"7","author":"SJ Wang","year":"1996","unstructured":"Wang SJ, Huang CC, Hsu KS, Tsai JJ, Gean PW (1996) Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones. Neuroreport 7:3037\u20133040","journal-title":"Neuroreport"},{"key":"2904_CR69","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/j.1460-9568.2008.06148.x","volume":"27","author":"C Winter","year":"2008","unstructured":"Winter C, Flash S, Klavir O, Klein J, Sohr R, Joel D (2008) The role of the subthalamic nucleus in \u2018compulsive\u2019 behavior in rats. Eur J Neurosci 27:1902\u20131911","journal-title":"Eur J Neurosci"},{"key":"2904_CR70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02253593","volume":"106","author":"H Zangrossi Jr","year":"1992","unstructured":"Zangrossi H Jr, Leite JR, Graeff FG (1992) Anxiolytic effect of carbamazepine in the elevated plus-maze: possible role of adenosine. Psychopharmacology (Berl) 106:85\u201389","journal-title":"Psychopharmacology (Berl)"},{"key":"2904_CR71","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/00207450600550428","volume":"116","author":"MR Zarrindast","year":"2006","unstructured":"Zarrindast MR, Ghadimi M, Ramezani-Tehrani B, Sahebgharani M (2006) Effect of GABA receptor agonists or antagonists on morphine-induced Straub tail in mice. Int J Neurosci 116:963\u2013973","journal-title":"Int J Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2904-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-012-2904-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2904-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T09:20:03Z","timestamp":1744795203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-012-2904-9"}},"subtitle":["Involvement of GABAergic system"],"short-title":[],"issued":{"date-parts":[[2012,10,21]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2904"],"URL":"https:\/\/doi.org\/10.1007\/s00213-012-2904-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,21]]}}}